Hepatorenal and renocardial syndrome in young patients with acute glomerulonephritis

In this paper we discuss classical types of acute glomerulonephritis in young adults, when the intake of paracetamol and diclofenac led to a dysfunctional and organic liver injury, at the same time it negatively affected the course of acute glomerulonephritis. To study the characteristics of the development of acute reno-cardial syndrome (ARCS) Goal: Assessment of cause and effect relations of renal, hearts and liver injuries in young adults in acute post-streptococcal glomerulonephritis (APSG). With acute nephritic syndrome (ANS) complicated by acute kidney injury (AKI) and without it, to identify the role of the etiological factor on the course of APSG. Methods and Material: 220 male patients with APSG with ANS aged 18-20 were examined. The patients were divided into 2 groups based on the functional state of kidneys. The first group included 140 patients with APSG without ANS, the second group included 80 patients with AKI. Results: Out 66 patients had subclinical liver injury, which resulted from the effect of antipyretic hepatotoxic drugs taken in the initial stage of the disease. Due to the toxic and immunological liver injury, levels of transaminases increase, and albumin levels decrease. These changes occur along with the development of APSG and are correlated with some laboratory values. Impairment of cardiovascular function was observed in all 220 patients. ECG and Echocardiography studies conducted during the cardiac asthma attacks occurred as a decrease of voltage, broadening of the P wave, lengthening of the PQ interval, broadening of the QRS complex, dilatations of the right and left atrium. The severity of clinical manifestations of AKI and ARCS correlates with the degree of macrohematuria, GFR decrease, complement C3 fraction, monocyte. Conclusion. In APSG liver injury has a toxicoallergic character. Frequency of liver injury depends on specific features of a particular organism, it does not depend on the dose of the taken drug. In case of any type of acute glomerulonephritis it is necessary to assess the functional state of liver and after the treatment of the main disease hepatologist follow-up of patients is recommended. Thus in the development of acute reno-cardial syndrome (ARCS) the degree of manifestation of hypervolemia with hypertension, as a result of active immune inflammation of the glomerular apparatus with the development of AKI, plays the main role in the development of ARCS with APSG.. As a rule ARCS in case of APSG with ANS in young adults has a successful outcome.

acute glomerulonephritis, subclinical hepatitis, Renocardiac Syndromes

1. Alyaev Yu.G., Amosov A. V., Androsova S. O. Nephrology. Moscow. Medicine Publ., 2010. 459 P. (In Russ.)@@ Аляев Ю. Г., Амосов А. В., Андросова С. О. / под ред. И. Е. Тареевой: Нефрология. М.: Медицина, 2010. 459 с.

2. Batyushin M. M., Povilaytite P. E. Clinical Nephrologyю Moscow. Dzhangar Publ., 2010. 682 P. (In Russ.)@@ Батюшин М. М. Повилайтите П. Е. Клиническая нефрология // М.: Джангар, 2010. -682 с.

3. Bian F. M., Kharlamov A. I. The Clinico-Immunological Characteristics of Acute Glomerulonephritis in the Military Population Undergoing Military Service by Call-up. Military Medical Journal., 2009, vol. 330, no. 2, pp. 76-77. (In Russ.) @@ Беня Ф. М., Харламов А. И. Клинико-иммунологическая характеристика острого гломерулонефрита у военнослужащих, проходящих военную службу по призыву // Воен.-мед. журн. 2009. - Т. 330, No 2. - С. 76-77.

4. Burova L. A., Gavrilova E. A., Pigarevsky P. V., Seliverstova V. G., Nagornev V. A., Schalen V. A., Totolian Artem A. Capacity of group a (type m12) streptococci to bind immune complexes and their role in pathogenesis of post-streptococcal glomerulonephritis. Medical Immunology (Russia). 2006;8(5-6):623-630. (In Russ.) doi: 10.15789/1563-0625-2006-5-6-623-630.@@ Бурова Л. А., Гаврилова Е. А., Пигаревский П. В., Селиверстова В. Г., Нагорнев В. А., Шален К., Тотолян Артем А. Способность стрептококков группы а типа м12 связывать иммунные комплексы и их роль в патогенезе постстрептококкового гломерулонефрита. Медицинская иммунология. 2006;8(5-6):623-630. doi: 10.15789/1563-0625-2006-5-6-623-630.

5. Dyadyk A. I., Bagry A. E., Yarovaya N. F., et al. Acute Post-Infectious Glomerulonephritis. News of Medicine and Pharmacy. Nephrology. 2009;297:101. (In Russ.)@@ Дядык А. И., Багрий А. Э., Яровая Н. Ф. и др. Острый постинфекционный гломерулонефрит // Новости медицины и фармации. Нефрология. 2009. - № 297. - С. 101.

6. Zhiznevskaya I. I., Khmelevskaya I. G. [Clinico-Laboratory Criteria of the Late Complications of Poststripctococcal Glomerulonephritis with Nephritic Syndrome in Children]. [Pediatrics: XIX в XXI centuries: Material II Russian Research Conference St. Petersburg, October 2010]. St. Petersburg, 2010. 27 P. (In Russ.)@@ Жизневская И. И., Хмелевская И. Г. Клинико-лабораторные критерии поздних осложнений острого постстрептококкового гломерулонефрита с нефритическим синдромом у детей // Педиатрия: из XIX в XXI век: материалы II Рос. науч. конф. (Санкт-Петербург, окт. 2010 г.). - СПб., 2010. - С. 27.

7. Minasyan A. M. [Clinico-Pathogenetic Characteristics and Pharmacotherapy of Cardiorenal Syndrome]. Yerevan, 2016, 21 P. (in Russ.)@@ Минасян А. М., Клинико-патогенетическая характеристика и фармакотерапия кардиоренального синдрома. Ереван, 2016 г., -С. 21.

8. Rakityanskaya I. A., et al. [Etiological Factors of Developing Acute Proliferative Glomerulonephritis]. Nephrology. 2000;(1):7-9. (in Russ.)@@ Ракитянская И. А. и др. Этиологические факторы развития острого пролиферативного гломерулонефрита./ «Нефрология» - 2000 г. -№ 1, - С.7-9.

9. Ryabov S. I. Nephrology. Special Literature Publ., 2013, Vol. 1, pp. 106-151. (in Russ.)@@ Рябов С. И. Нефрология. Том 1, Спецлит. - 2013 - С.106-151.

10. Ivashkin V. T. [Rational pharmacotherapy for diseases of the digestive system. 2nd edition]. Moscow. Mitter Publ., 2011, 424 P. (in Russ.)@@ Ивашкин В.Т Рациональная фармакотерапия заболевании органов пищеварения. 2-е издание М. Миттера, 2011. ст. 424.

11. Shipov E. I. Nephrology. Clinical Recommendations. Geotar Media Publ., 2016, pp. 203-204. (in Russ.)@@ Шипов Е. И. Нефрология. Клинические рекомендации. Гэотар-медиа 2016 г. сс. 203-204.

12. Shulutko B. I. Acute Glomerulonephritis, and not Only in the XXI century. Nephrology. 2015;19(6):14-19. (in Russ.)@@ Шулутко Б. И. Острый гломерулонефрит, и не только в XXI веке. Нефрология. 2015 г. -Том. 19, -№. 6, - С.14-19.

13. Tsygin A. N. [The Combined Diseases of a Liver and Kidneys in Children]. Klien, Nephrology. 2009;(3):47-51. (In Russ.)@@ Цыгин А. Н. Сочетанные заболевания печени и почек у детей // Клин, нефрология. 2009. - № 3. - С. 47-51.

14. Ahn S. Y., Ingulli E. Acute poststreptococcal glomerulonephritis: an update. Curr Opin Pediatr. 2008 Apr;20(2):157-62. doi: 10.1097/MOP.0b013e3282f45bcf.

15. Andrade R. J., Robles M., Fernández-Castañer A., López-Ortega S., López-Vega M.C., Lucena M. I. Assessment of drug-induced hepatotoxicity in clinical practice: a challenge for gastroenterologists. World J Gastroenterol. 2007 Jan 21;13(3):329-40. doi: 10.3748/wjg.v13.i3.329.

16. Chuasuwan A., Kellum J. A. Cardio-renal syndrome type 3: epidemiology, pathophysiology, and treatment. Semin Nephrol. 2012 Jan;32(1):31-9. doi: 10.1016/j.semnephrol.2011.11.005.

17. Chang C. Y., Schiano T. D. Review article: drug hepatotoxicity. Aliment Pharmacol Ther. 2007 May 15;25(10):1135-51. doi: 10.1111/j.1365-2036.2007.03307.x.

18. Kingma J. G. Jr, Simard D., Rouleau J. R. Renocardiac syndromes: physiopathology and treatment stratagems. Can J Kidney Health Dis. 2015 Oct 16;2:41. doi: 10.1186/s40697-015-0075-4.

19. Roy R, Arhter A. A., Rahman M. A. Hypertensive Cardiogenic Shock in Children with Acute Poststreptococcal Glomerulonephritis. An Unusual Presentation. - A Case Report. I. Ped. Nephrology. 2015;3(4):170-173.

20. Idhate T., Zaki S. A., Shanbag P. Cardiac status in children with acute poststreptococcal glomerulonephritis. Saudi J Kidney Dis Transpl. 2017 Jul-Aug;28(4):830-835. PMID: 28748885.